| cilostazol / Generic mfg. |
NCT00404716: Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation |
|
|
| Completed | 4 | | RoW | Cilostazol | Shenyang Northern Hospital | Acute Coronary Syndrome | | 02/07 | | |
NCT00404781: Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention |
|
|
| Completed | 4 | 305 | RoW | cilostazol in addition to aspirin and clopidogrel | Shenyang Northern Hospital | Ischemic Heart Disease, Acute Coronary Syndromes | 06/07 | 06/07 | | |
NCT00431249: Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease |
|
|
| Completed | 4 | 40 | RoW | Cilostazol | Tungs' Taichung Metroharbour Hospital | Hemodialysis Patients, Peripheral Vascular Disease | 04/08 | 04/08 | | |
| Completed | 4 | 244 | RoW | Cilostazol, pletaal, placebo, matching placebo of cilostazol | Asan Medical Center, Korea Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 06/08 | 07/08 | | |
NCT00272454: Cilostazol in Acute Ischemic Stroke Treatment (CAIST) |
|
|
| Completed | 4 | 468 | RoW | Cilostazol, Aspirin | Korea Otsuka Pharmaceutical Co., Ltd., Seoul National University Boramae Hospital, Korea Otsuka International Asia Arab Co., Ltd. | Cerebral Infarction | | 09/08 | | |
ECLIPse, NCT00741286: Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler |
|
|
| Completed | 4 | 203 | RoW | Aspirin, cilostazol, Pletaal | Inje University, Korea Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 10/08 | 10/08 | | |
NCT00234065: Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) |
|
|
| Completed | 4 | 2800 | Japan | Cilostazol, Aspirin | Otsuka Pharmaceutical Co., Ltd. | Cerebral Infarction | 12/08 | 12/08 | | |
| Completed | 4 | 457 | RoW | clopidogrel, Plavix, produced by Sanofi-Aventis., Cilostazol, cilostazol produced by Korea Otsuka Pharmaceutical | Asan Medical Center, Korea Otsuka International Asia Arab | Cerebral Infarction, Atherosclerosis | 01/09 | 01/09 | | |
ACCEL-2C19, NCT01012193: Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism |
|
|
| Completed | 4 | 134 | RoW | cilostazol 100mg bid or clopidogrel 150-mg daily | Gyeongsang National University Hospital | Coronary Artery Disease, Percutaneous Coronary Intervention | 07/09 | 09/09 | | |
NCT00823849: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker |
|
|
| Completed | 4 | 200 | RoW | Cilostazol, pletaal, Probucol, Changtai, Cilostazol+Probucol, Pletaal and Changtai, Control Group, Routine treatment | Otsuka Beijing Research Institute | Type 2 Diabetes Mellitus, Arteriosclerosis Obliterans | 08/09 | 03/10 | | |
ACCEL-AMI-2C19, NCT00915733: Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism |
|
|
| Completed | 4 | 80 | RoW | cilostazol, Otsuka brand of cilostazol, clopidogrel (Plavix), Plavix, CYP2C19, Cytochrome 2C19, aspirin (Acetylsalicylic acid), Acetylsalicylic acid | Gyeongsang National University Hospital | Myocardial Infarction | 10/09 | 11/09 | | |
NCT00823875: Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject |
|
|
| Completed | 4 | 200 | RoW | Cilostazol group, Pletaal, Probucol group, Changtai, Cilostazol + Probucol group, Pletaal and Changtai, control group, Routine Treatment | Otsuka Beijing Research Institute | Atherosclerosis Cerebral Infarction | 12/09 | 07/10 | | |
PIANO-CKD2, NCT01328470: Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease |
|
|
| Completed | 4 | 85 | RoW | Clopidogrel, cilostazol, Plavix, pletaal | Kyunghee University Medical Center | Chronic Kidney Disease, Stable Angina | 08/10 | 08/10 | | |
CAVAD, NCT00847860: Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions |
|
|
| Completed | 4 | 200 | RoW | Cilostazol, Aspirin | Peking University First Hospital, Zhejiang Otsuka Pharmaceutical Co., Ltd. | Vascular Dementia, Stroke | 05/11 | 06/11 | | |
NCT01094457: Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation |
|
|
| Completed | 4 | 840 | RoW | aspirin, clopidogrel, aspirin, clopidogrel, cilostazol | Shenyang Northern Hospital | Acute Coronary Syndromes, Percutaneous Coronary Intervention, Clopidogrel Low Responsiveness | 04/12 | 06/12 | | |
| Completed | 4 | 220 | RoW | Dual Anti-Platelet Therapy (DAPT), Triple Anti-Platelet Therapy (TAPT) | Gyeongsang National University Hospital | Platelet Aggregation Inhibitors, Anti-inflammatory Agent, Myocardial Reperfusion Injury | 07/12 | | | |
ABCD, NCT01192724: Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation |
|
|
| Completed | 4 | 630 | RoW | Cilostazol, pletaal, Aspirin, Aspirin protect, Astrix, Baby rhonal, Clopidogrel, Plavix, Plavitor, Platless | Yonsei University | Coronary Artery Disease | 12/12 | 12/12 | | |
NCT01188824: The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study) |
|
|
| Completed | 4 | 801 | RoW | Cilostazol, Pletaal®, placebo | China Medical University Hospital, National Taiwan University Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tri-Service General Hospital, Far Eastern Memorial Hospital, Changhua Christian Hospital, Chi Mei Medical Hospital, National Cheng-Kung University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, E-DA Hospital, Mackay Memorial Hospital, Cathay General Hospital, En Chu Kong Hospital, Kuang Tien General Hospital, Chung Shan Medical University, Taipei Veterans General Hospital, Taiwan | Ischemic Stroke | 07/13 | 07/13 | | |
NCT01952756: Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD) |
|
|
| Completed | 4 | 44 | RoW | Cilostazol, Pletaal (brand name), Dummy Placebo, Placebo, Control | National Cheng-Kung University Hospital, Department of Health, Executive Yuan, R.O.C. (Taiwan) | Peripheral Arterial Diseases | 09/13 | 09/13 | | |
| Terminated | 4 | 402 | RoW | Cilostazol, Pletaal, Placebo | Seung-Jung Park, Otsuka Pharmaceutical Development & Commercialization, Inc. | Coronary Artery Disease | 02/15 | 02/15 | | |
NCT01995370: Cilostazol Stroke Prevention Study for Antiplatelet Combination |
|
|
| Completed | 4 | 1884 | Japan | aspirin, Bayaspirin, clopidogrel, Plavix, cilostazol, Pletaal OD Tablet | Japan Cardiovascular Research Foundation, Otsuka Pharmaceutical Co., Ltd. | Noncardioembolic Cerebral Infarction | 12/18 | 12/18 | | |
